SOP Guide for Pharma

Analytical Method Development: SOP for Residual Oxygen Testing by GC – V 2.0

Analytical Method Development: SOP for Residual Oxygen Testing by GC – V 2.0

Standard Operating Procedure for Residual Oxygen Testing Using Gas Chromatography


Department Analytical Method Development
SOP No. SOP/AMD/183/2025
Supersedes SOP/AMD/183/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP establishes a validated analytical procedure for determining residual oxygen content in pharmaceutical container headspace using Gas Chromatography (GC) equipped with a Thermal Conductivity Detector (TCD) or Barrier Discharge Ionization Detector (BID). This

test ensures the effectiveness of nitrogen purging, container closure integrity, and product stability.

2. Scope

This procedure applies to ampoules, vials, and pre-filled syringes filled with sterile injectables or lyophilized products packaged under nitrogen atmosphere, and is intended for use in development, validation, and quality control testing.

3. Responsibilities

  • Analytical Scientist: Develops and validates the GC method for oxygen detection.
  • QC Analyst: Prepares standards, samples, and runs GC analysis as per protocol.
  • QA Officer: Ensures the reviewed results meet acceptance criteria and regulatory expectations.
  • Head – AMD: Approves the method and oversees its implementation in GMP settings.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring the residual oxygen test method meets analytical performance standards and supports product shelf-life claims.

5. Procedure

5.1 Instrument and Detector Configuration

  1. Use GC system equipped with:
    • Thermal Conductivity Detector (TCD) or Barrier Discharge Ionization Detector (BID)
    • Molecular sieve column (e.g., 5Å or porous polymer column)
    • Headspace autosampler (preferred)
  2. Carrier gas: Helium or Nitrogen
  3. Column temp: 40°C isothermal; Injector: 150°C; Detector: 200°C
  4. Record baseline and calibration in Annexure-1: GC Calibration Log

5.2 Standard Preparation

  1. Use certified calibration gas mixtures containing 1%, 5%, 10% oxygen in nitrogen.
  2. Transfer known volumes into headspace vials and seal immediately with crimp caps.
  3. Ensure gas-tight sealing and consistent vial volumes across standards and test samples.

5.3 Sample Handling and Testing

  1. Transfer sample containers from cold storage to room temperature (25 ± 2°C).
  2. Wipe each container to remove surface contaminants.
  3. Puncture the rubber closure using automated headspace sampling needle or manual gastight syringe.
  4. Inject fixed headspace volume (e.g., 1 mL) into GC system.
  5. Perform blank and standard runs before each batch.
  6. Calculate oxygen % in headspace using calibration curve.
  7. Log all results in Annexure-2: Residual Oxygen Report.

5.4 Method Validation

  1. Validate as per ICH Q2(R2) and USP <1207> guidelines:
    • Linearity: 1% to 20% oxygen (R² ≥ 0.995)
    • LOD/LOQ: Detect and quantify levels down to 0.5% if applicable
    • Precision: RSD ≤ 3% at 5% oxygen
    • Accuracy: Recovery 95%–105%
    • Robustness: Assess at different vial sizes and needle depths
  2. Summarize validation in Annexure-3: GC Validation Summary

5.5 Acceptance Criteria

  1. Residual oxygen ≤ 1.0% (for nitrogen-filled containers unless otherwise justified)
  2. No leakage or compromised closure integrity
  3. Consistent results across replicate containers (n = 3 minimum)

6. Abbreviations

  • GC: Gas Chromatography
  • TCD: Thermal Conductivity Detector
  • BID: Barrier Discharge Ionization Detector
  • LOD: Limit of Detection
  • LOQ: Limit of Quantification
  • SOP: Standard Operating Procedure

7. Documents

  1. GC Calibration Log – Annexure-1
  2. Residual Oxygen Report – Annexure-2
  3. GC Validation Summary – Annexure-3

8. References

  • USP <1207> – Package Integrity Evaluation
  • ICH Q2(R2) – Validation of Analytical Procedures
  • FDA Guidance – Container Closure Systems for Packaging Human Drugs
  • European Pharmacopoeia – Residual Oxygen Test

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: GC Calibration Log

Date Std. Gas (% O₂) Response (Area) R² Value Analyst
18/05/2025 5.0% 18276 0.9986 Rajesh Kumar

Annexure-2: Residual Oxygen Report

Container ID Sample Type O₂ Content (%) Acceptance Limit (%) Status
VIAL-245 Lyophilized 0.8 ≤1.0 Complies

Annexure-3: GC Validation Summary

Parameter Result Criteria Status
Precision RSD = 2.1% ≤ 3% Pass
Accuracy 96.3% 95–105% Pass
LOD 0.3% ≤ 0.5% Pass

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Updated calibration gases and detection parameters Regulatory audit readiness
Exit mobile version